Novavax begins mid-stage study of COVID-19 vaccine in South Africa
US drug developer Novavax Inc said on Monday it started a mid-stage study of its experimental COVID-19 vaccine in South Africa, as the country experiences a surge in coronavirus cases.
from bdnews24.com - Home https://ift.tt/3ax5ufH
from bdnews24.com - Home https://ift.tt/3ax5ufH
No comments